Tweets
RheumNow’s expanded coverage of the #ACR26 Annual Meeting is sponsored by Eli Lilly and Company.
All coverage content is independently selected by RheumNow and its faculty.
Dr. John Cush @RheumNow ( View Tweet )
6 minutes 28 seconds ago
Basic Sci Yr in Rvw #ACR26
Role of EBV+ B cells in SLE- resistant to killing w anti-CD20 and CD19 Ab
Acute depletion leads to B cell reconstition without immune reset
CD-19 CAR-T can effectively resent EBV+ B cells
@RheumNow https://t.co/fs30bpjWWF
Links:
Eric Dein @ericdeinmd ( View Tweet )
9 minutes 14 seconds ago
Basic Sci Yr in Rvw #ACR26
Pyrin ligand: CDC42 binds B30.2
MEFV gene in Med Fever lie in B30.2
CDC42-opathy joins IL-1 responsive autoinflamm diseases
VEXAS- 2 mech from UBA1 Met41 mutations
1. Mutant macrophages die by apoptosis, necroptosis
2. Unfolded prot response
@RheumNow https://t.co/ki1jSZnJIu
Links:
Eric Dein @ericdeinmd ( View Tweet )
9 minutes 16 seconds ago
YIR: Why does RA affect PIPs and not DIPs? This study demonstrates that Joint-specific susceptibility is established embryonically:
PIP jts - larger synovial vol & PI16+ fibroblasts
Implications? Provides developmental exp why particular jts are affected
@RheumNow #ACR26 https://t.co/easfYOl5Ee
sheila @RHEUMarampa ( View Tweet )
9 minutes 19 seconds ago
Role of OA in HTN?
Basic Sci Yr in Rvw #ACR26
HTN fuels OA via Arginine Vasopressin (AVP)-AVPR1A
HTN associates w OA incidence/severity
OA-primed chondrocytes upregulate AVPR1A - dri2ves cartilage catabolism
Damage reversible
@RheumNow https://t.co/j1AELAntLQ
Links:
Eric Dein @ericdeinmd ( View Tweet )
9 minutes 25 seconds ago
YIR: This study fr Dr. W Robinson show that activated-naive autoreactive B cells expand before clinical arthritis
Clinical implications? Potential target for RA prevention.
@RheumNow #ACR26 https://t.co/uIG3kTIBzV
sheila @RHEUMarampa ( View Tweet )
9 minutes 41 seconds ago
Basic Sci Yr in Rvw
Pre-clinical RA: senescent-like activated B cells expand before clinical RA, present citrullinated Ag
2 seqen stages:
1. Type 1 IFN stage BEFORE subclinical syn
2. Cytotoxic GZMB+ stage
Type 1 IFN affects nociceptors -> pain before arthritis
@RheumNow #ACR26 https://t.co/VGAQuC0G1X
Eric Dein @ericdeinmd ( View Tweet )
11 minutes 2 seconds ago
#CHAI has #AI that is the largest not for profit organization in #healthcare
#keynote @ACRheum #ACR26
Example of #artificial #intelligence involves targets for #CAR-T
#CD19, #CD20, #CD22 and #BCMA
@RheumNow https://t.co/ZCENzmnNTN
Janet Pope @Janetbirdope ( View Tweet )
1 hour 38 minutes ago
"Implicit cognitive bias not only is unfair but also leads to worse patient outcomes" -Laure Gossec-Incoming EULAR president.
Implicit bias (brain predicts before finishing listening) from healthcare providers affects pain assessment and management.
Education is the way to https://t.co/7zWODNZWdd
Links:
Adela Castro @AdelaCastro222 ( View Tweet )
1 hour 40 minutes ago
aPL vs APS in Pregnancy: Same Antibody, Different Plan
-aPL but no APS: no anticoagulation; low-dose aspirin (LDASA) may reduce preeclampsia risk
-Obstetric APS: LDASA + prophylactic LMWH, continued through 6 weeks postpartum
-Thrombotic APS: LDASA + treatment-dose LMWH;
Adela Castro @AdelaCastro222 ( View Tweet )
10 hours 5 minutes ago
Links:
Dr. John Cush @RheumNow ( View Tweet )
12 hours 14 minutes ago
#Vaccinate your #SARD Pts esp if given strong #immune #suppression
#Taiwan #College of #Rheumatology
#recommendations for #vaccines
Pre & Post #CAR-T
Can apply for #IMMUNESUPPRESSED
Pts in general who get #B #cell #depletion
#ACR26 abst#2773
@RheumNow https://t.co/34xcBjsD99
Janet Pope @Janetbirdope ( View Tweet )
12 hours 22 minutes ago
Treatment for ICI-IrAEs:
•Early immunosuppression/high doses of steroids (first 2 months) associated with worse survival.
•ICI-IA: TNFi and IL-6Ri mostly used
•ICI-PMR: steroids/IL6Ri
•ICI-myositis: steroids/IVIG mostly used.
•Little data on effects of long-term
Adela Castro @AdelaCastro222 ( View Tweet )
12 hours 23 minutes ago
Immune-Related Adverse Events:
ICI-IA: the most common rheumatic irAE-> Heterogeneous presentation. 50-78% persist >6m after stopping ICI. Usually seronegative and have elevated inflammatory markers.
ICI-PMR: some pt with peripheral inflammatory arthritis, less likely comorbid https://t.co/Ad5FPGZ8nP
Adela Castro @AdelaCastro222 ( View Tweet )
12 hours 23 minutes ago
Importance of genetics in rheumatic diseases
#ACR26 #ReviewCourse @RheumNow https://t.co/weDtEQH0Cb
Adela Castro @AdelaCastro222 ( View Tweet )
12 hours 23 minutes ago


